Vaxalto Biotherapeutics, Inc.
https://www.vaxalto.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Vaxalto Biotherapeutics, Inc.
Tech Transfer Roundup: MD Anderson Working To Unlock Promise Of Tumor-Infiltrating Lymphocytes
The center is partnering with Obsidian to make autologous TILs work better after being infused back into patients by using IL-15, which may be less toxic than the high-dose IL-2 currently used.
Company Information
- Industry
-
Biotechnology
- Gene Therapy, Cell Therapy
- Large Molecule
-
Large Molecule
- Antibodies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice